✦ LIBER ✦

What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?

✍ Scribed by P. Petrini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylactic treatment with FEIBA of a h

✍ B. Siegmund; H. Richter; H. Pollmann 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Treatment related factors and inhibitor

✍ P. S. MACLEAN; M. RICHARDS; M. WILLIAMS; P. COLLINS; R. LIESNER; D. M. KEELING; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Treatment of intracranial and extracrani

✍ G. M. T. Guilcher; M.-F. Scully; M. Harvey; J. P. Hand 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

The benefits of prophylactic treatment w

✍ L. A. VALENTINO 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Comparative effectiveness of plasma-deri

✍ H. Pollmann; H. Richter; B. Siegmund 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The safety and efficacy of B-domain dele

✍ J. M. Lusher; D. A. Roth 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB